Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma

Journal of Urology

Volumn 163, Issue 4, 2000, Pages 1120-1123

  Kondylis, F I ^a   Demirci, S ^a   Ladaga, L ^a   Kolm, P ^a   Schellhammer, P F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Bladder; Bladder neoplasms; Carcinoma; Neoplasm staging; Transitional cell

Indexed keywords

BCG VACCINE;

ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0034121489     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67706-3     Document Type: Article

References (22)

1. Heney, N. M., Ahmed, S., Flanigan, M. J. et al: Superficial bladder cancer: progression and recurrence. J Urol, 130: 1083, 1983
2. Lutzeyer, W., Rübben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol, 127: 250, 1982
3. Fujii, Y., Fukui, I., Kihara, K. et al: Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol, 33: 464, 1998
4. Sarosdy, M. F.: Management of high grade superficial bladder cancer. Role of BCG, AUA Update Series, vol. XVII, Lesson 12, 1998
5. Hasui, Y., Osada, Y., Kitada, S. et al: Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology, 43: 782, 1994
6. Angulo, J. C., Lopez, J. I., Grignon, D. J. et al: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 45: 47, 1995
7. Dixon, J. S. and Gosling, J. A.: Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat, 136: 265, 1983
8. Younes, M., Sussman, J. and True, L. D.: The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer, 66: 543, 1990
9. Ro, J. Y., Ayala, A. G. and El-Naggar, A.: Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol, 11: 668, 1987
10. Eure, G. R., Cundiff, M. R. and Schellhammer, P. F.: Bacillus Calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J Urol, 147: 376, 1992
11. Pansadoro, V., Emiliozzi, P., Defidio, L. et al: Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J Urol, 154: 2054, 1995
12. Herr, H. W.: Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J Urol, 145: 40, 1991
13. Pham, H. T. and Soloway, M. S.: High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder. Semin Urol Oncol, 15: 147, 1997
14. Birch, B. R. P. and Harland, S. J.: The pT1G3 bladder tumour. Br J Urol, 64: 109, 1989
15. Engel, P., Anagnostaki, L. and Braendstrup, O.: The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies. Scand J Urol Nephrol, 26: 249, 1992
16. Zhang, G. K., Uke, E. T., Sharer, W. C. et al: Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. J Urol, 155: 1907, 1996
17. Dal Bo, V., Belmonte, P., Verones, A. et al: Intravesical BCG instillations in patients with carcinoma in situ and PT1 G3 transitional cell carcinoma of the bladder. Eur Urol, suppl., 18: 43, 1990
18. Lebret, T., Becette, V., Barbagelatta, M. et al: Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer. J Urol, 159: 788, 1998
19. Herr, H. W., Jaskse, G. and Sheinfeld J.: The T1 bladder tumor. Semin Urol, 8: 254, 1990
20. Cookson, M. S. and Sarosdy, M. F.: Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin Therapy. J Urol, 148: 797, 1992
21. Smits, G., Schaafsma, E., Kiemeney, L. et al: Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology, 52: 1009, 1998
22. Holmäng, S., Hedelin, H., Anderström, C. et al: The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol, 157: 800, 1997